To accelerate the development of biotechnology as a strategic emerging industry and cultivate new growth points, on 17 December 2020, Xiamen Vice Mayor Huang Xiaozhou and a delegation of 7 visited Beike Biotech for inspection, seeking points of cooperation and exploring new development opportunities. Dr. Hu Junyuan, Chairman of Beike Biotech, warmly received the delegation.
Vice Mayor Huang Xiaozhou and his delegation first visited the Shenzhen Comprehensive Cell Bank and the Shenzhen Comprehensive Cell Bank Science Education Hall. Dr. Hu led the leaders on a tour of the Shenzhen Comprehensive Cell Bank, the infrastructure for Shenzhen's life and health industry, and the Shenzhen Comprehensive Cell Bank Science Education Hall, a base of the Nanshan District Children's Science Education Alliance.
At the Shenzhen Comprehensive Cell Bank Science Education Hall, the leaders gained an in-depth understanding of Beike Biotech's and the Shenzhen Comprehensive Cell Bank's honors and qualifications, technological development and research achievements. Vice Mayor Huang Xiaozhou and the accompanying leaders showed great interest in stem cell and immune cell technology and expressed strong optimism about the development of the cell industry.
At the discussion meeting, Dr. Hu Junyuan, Chairman of Beike Biotech, briefed the visiting leaders on the core technologies Beike Biotech holds in the stem cell field, the progress of current research projects, future development strategy and the prospects of AI in the future of biomedicine. Dr. Hu noted that the current pandemic has brought a major opportunity for the development of the major-health industry. Beike Biotech possesses a top-tier stem cell research team and frontier technologies for cell storage and preparation. Its innovative "one bank, one center, one platform" development model provides an innovative public technology platform and infrastructure for the clinical translation of cell therapy technology, while also laying a data foundation for the future development of AI + biomedicine.
Vice Mayor Huang Xiaozhou said that the strong momentum in the major-health industry is encouraging, and he highly commended Beike Biotech's development concepts and accomplishments in cell technology and biotherapeutics. As one of Xiamen's ten key areas for industrial upgrading, in recent years Xiamen has fully leveraged its advantages as one of the first pilot cities for the National Health and Medical Big Data Center, advancing the development of the biopharmaceutical and health industry citywide and attracting many enterprises to come and seize the development opportunities, expand cooperation and join Xiamen in building a "City of Life Sciences and Technology of China". As a leader in China's cell field, Beike Biotech is exactly the kind of "capable partner" Xiamen urgently needs to develop its biopharmaceutical and health industry. He hoped that cooperation could be advanced in the future, bringing new rapid development and opportunities to the biopharmaceutical and health industry on this fertile ground in Xiamen.
